We demonstrated significantly more favorable neuropathological characteristics, such as IDH1-mutation, lack of anaplasia and lower mitotic rates in incidental diffuse and anaplastic gliomas compared to a group of symptomatic gliomas. Here, IDH1 is linked to central nervous system cancer.